Advanced Medical Publishing 
Send e-mail to Advanced Medical Publishing
Book Search:   
<< Back  Frontlist Titles  About Us  How To Order  Update Profile  Home

Radiation Oncology (Physics)

Basic Therapy Physics

   Radiation physics
Treatment Planning
   Basic treatment planning
   3-D conformal therapy
   3-D conformal & IMRT
   Imaging in treatment planning
   Intensity modulated RT (IMRT)
   Inverse treatment planning
   CT-simulation
Imaging 
   Basic principle
   3D 
   CT
   MRI
   PET
   Ultrasound
IGRT
   Lung
   Neurosurgery
   Prostate
Dosimetry
   General
   Intraoperative
   Photon & electron
   Monitor Unit
   Neutron
Brachytherapy
   General
   Intra-vascular
   High-dose rate
   Low-dose rate
   Monte carlo dosimetry
   Pediatric
   Quality assurance
Dosimetrist
   Clinical
   Physics
   Brachytherapy
   Radiobiology
   CT-Simulation
Radiation Therapists
Radiation Therapists
   Clinical
   Physics
   Radiation protection
Special Procedures
   Intraoperative
   Hyperthermia
   Neutron capture therapy
   Stereotactic radiosurgery
Linear Accelerator
Radiation & Cancer Biology
2016
   Basic
   Applied
   Clinical
   Annual Online Exams
   Rabex Online Exams
   2015
   2016
   2017
   2018
   Rabex Online Exam for Dosimetrist
   2018
   Radiobiology Practice  2018
Radiation Detection 
Radiation Protection
Health Physics
Educational & Exam Materials 
What's New
Upcoming Titles
New Releases
AMP Releases
Hot Sellers
Radiation Oncology (Clinical)

Clinical Oncology

   Essential textbooks
IGRT
   Neurosurgery
   Prostate
   Lung
Special Topics
   Breast
   CNS
   Endocrine
   Head & Neck
   Gynecological
   Gastrointestinal
   Genitourinary
   Leukemias & Lymphomas
   Lung
   Neuro-Oncology
   Ophthalmic-Oncology
   Pediatric
   Prostate
    Skeletal
   Skin
Staging
   AJCC
   Color-matrix staging
   Staging atlas
   TNM classification
Surgical Oncology
Treatment Planning
   Basic treatment planning
   3-D conformal & IMRT
   3-D conformal therapy
   Intensity modulated RT (IMRT)
   CT-simulation
Physics
   Basic & clinical
Brachytherapy
   General
   Intra-vascular
   High-dose rate
   Low-dose rate
   Pediatric
   Quality assurance
Special procedure
   Intraoperative
   Stereotactic radiosurgery
   Neutron capture therapy
   Hyperthermia
Imaging
   Abdomen
   Breast
   Extremities
   Head & Neck
   Heart
   Pediatric chest
   Pelvis
   Spine
   Thorax
   CT 
   MRI
   PET
   Oncologic
   Ultrasound
Oncologic Nursing
Radiobiology
Educational Materials for Residents
   Physics
   Radiobiology
   Biological model
   Clinical
Research 
What's New
Upcoming Titles


For new releases and newsletters, Sign-Up now!



 Genitourinary
Bladder Cancer: Current Diagnosis and Treatment  
 
Michael J. Droller, MD, Mount Sinai School of Medicine, New York, NY 
Qty:      
Email this page to a friend

Description:

Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and management of bladder cancer. Their comprehensive discussion summarizes the state-of-the-art in diagnosis and treatment, based on the latest understanding of bladder cancer’s epidemiology, carcinogenesis, and tumor markers. Topics of particular interest include the role of genetics and molecular biology in evaluating bladder cancer clinically, the evaluation of the results of systemic treatment in advanced disease, the current status of tumor markers in bladder cancer, and the means for further study in their applicability. Insightful and evidenced-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art tutorial on today’s optimal assessment and treatment of bladder cancer.

Contents:

Demographic and Epidemiologic Aspects of Bladder Cancer, Gunnar Steineck. Biology and Molecular Aspects of Development and Progress of Bladder Cancer, Dan Theodorescu and William A. See. Diagnosis of Bladder Cancer, Ichabod Jung, Edward M. Messing and Yves Fradet. Diagnostic Imaging in Urothelial Cancer,Lynn Ladetsky, Harold Mitty and Rosaleen B. Parsons. Urinary Cytology and Its Role in Diagnosis and Monitoring in Urothelial Carcinoma, Hans Wijkström, William C. Baker, Arline D. Deitch and Ralph W. deVere White. The Use of Tumor Markers in Bladder Cancer and Current Concepts on Clinical Applicability, H. Barton Grossman. Pathologic Assessment of Bladder Cancer and Pitfalls In Staging, Christer Busch, Debra Hawes, Sonny L. Johansson and Richard J. Cote. Use of Intravesical Chemotherapy in Treatment of Superficial Bladder Cancer, Vincent G. Bird, Mark S. Soloway and Per-Uno Malmström. Use of Intravesical BCG in Treatment of Superficial Bladder Cancer, Michael A. O’Donnell. Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer, John P. Stein, Donald G. Skinner and James E. Montie. Considerations in the Use of Neoadjuvant and Adjunctive Systemic Chemotherapy in Treatment of Invasive Bladder Cancer by Cystectomy, Seth P. Lerner and Derek Raghavan. Clinical Situations for the Role of Radiation in the Treatment of Bladder Cancer, Mary K. Gospodarowicz, M.F. Milosevic, P. Warde and Arthur Porter. Current Concepts for Urinary Diversion in Men, Courtney M.P. Hollowell, Gary D. Steinberg and Randall G. Rowland. Current Concepts of Urinary Diversion in Women, Arnulf Stenzl and Georg Bartsch. Current Prospects for the Use of Molecular Markers in Treatment of Bladder Cancer by Cystectomy or Bladder-Conserving Approaches, Guido Dalbagni, Carlos Cordon-Cardo and Joel Sheinfeld. New Possibilities in Systemic Treatment for Metastatic Bladder Cancer, Randall F. Millikan and Simon Hall. Statistical Consideration in the Phase 2 Evaluation of New Therapy. Randall F. Millikan and Peter F. Thal.

Michael J. Droller, MD, Mount Sinai School of Medicine, New York, NY
454 Pages, July 2001, Hardcover
$140.00 U.S.
ISBN: 0-89603-818-1  
email: info@advmedpub.net
Qty:      
   
<< Back   Top of Page   Email this page to a friend



PLEASE VISIT OUR SPONSORS...
CMS Inc. manufactures, markets, and supports FOCUS, an advanced 3D RTP system, IMRT, Focal products, and DynaScan dosimetry systems. For additional information please visit our Website, www.cms-stl.com.
  
ODS, Inc. provides MuCheck - a customized independent monitor unit calculation program. Also a new product IMRT Check (FDA Market Clearance) for verification of dose for static or dynamic IMRT plans. For additional information please visit our Website, www.mucheck.com.
Search and you shall find on www.lifelinesoftware.com. the first and most comprehensive QA software program FDA 510(k) approved to perform independent MU or point dose verification calculations for both conventional and IMRT Treatment Planning Systems!


© 1994- Advanced Medical Publishing. All Rights Reserved.



Web Design by
Netphoria Inc.
Netphoria Inc.